Visual Field Test Logo

Argus ii

आपके दृष्टि स्वास्थ्य को बनाए रखने के लिए गहन शोध और विशेषज्ञ मार्गदर्शिकाएँ।

Искусственное зрение при терминальной глаукоме: ретинальные против кортикальных протезов

Искусственное зрение при терминальной глаукоме: ретинальные против кортикальных протезов

Искусственное зрение при терминальной глаукоме: ретинальные против кортикальных протезов Прогрессирующая глаукома разрушает зрительный нерв и ганглиоз...

晚期青光眼的仿生视觉:视网膜假体与皮层假体比较

晚期青光眼的仿生视觉:视网膜假体与皮层假体比较

晚期青光眼的仿生视觉:视网膜假体与皮层假体比较 晚期青光眼会杀死视神经和视网膜神经节细胞(RGCs),导致患者失明。仿生视觉(视觉假体)旨在绕过此类损伤。大多数现有假体针对视网膜或视神经,但在晚期青光眼患者中,这些通路已经消失。因此,研究人员正在探索直接刺激视觉皮层(大脑)的植入物。本文比较了用于青...

अपनी दृष्टि की जांच करने के लिए तैयार हैं?

5 मिनट से कम समय में अपना मुफ्त विज़ुअल फ़ील्ड टेस्ट शुरू करें।

अभी टेस्ट शुरू करें

Argus II

Argus II is a specific retinal implant system developed to give people with severe retinal degeneration a form of artificial vision by electrically stimulating the remaining retinal cells. The system uses a small array of electrodes that is implanted on the surface of the retina, together with glasses housing a camera and a processing unit that converts visual information into electrical pulses. When worn and activated, the device produces patterns of light perception that recipients can learn to interpret as edges, motion, or basic shapes, which can help with navigation and object detection. The experience is not like natural sight; it provides low-resolution, high-contrast signals that require training and rehabilitation to be useful in daily life. Argus II was one of the first retinal prosthesis systems to be used widely in clinical settings and to receive regulatory approvals, which helped establish standards for safety and effectiveness in the field. Users report benefits such as improved orientation, easier mobility, and greater independence, though outcomes vary across individuals. Surgical implantation carries risks, and the system has limitations in image detail, update speed, and long-term electrode performance. Despite these limits, Argus II represented an important milestone that encouraged further research and development in devices aiming to restore vision. Ongoing work builds on lessons from Argus II to improve resolution, biocompatibility, and the range of people who might benefit.